search
Front > News

HU tech transfer co Yissum seeks to raise fund

22 Jun, 2011 17:59
שלח תגובה במיילGali Weinreb

The fund will focus on drug development companies that have graduated from Yissum.

Sources inform ''Globes'' that Yissum Technology Transfer Company of the Hebrew University of Jerusalem is raising a fund for investment in companies that graduated from it. The fund will total tens of millions of dollars, which will be invested in drug development companies that were founded at Yissum, including companies whose technology has already been commercialized by Yissum as start-ups. The fund will incorporate all of Yissum's current holdings and will make additional investments in companies.

Yissum declined to comment on the report.

Israeli financial institutions will be the main investors in the fund, possibly as part of the government program for encouraging institutional investment in venture capital funds.

Yissum's portfolio companies that might fit the fund's objectives include Atox Bio Ltd., which is developing a treatment for toxic shock syndrome and autoimmune diseases; Tiltan Pharma Ltd., which is developing a treatment for cancer to be taken in conjunction with current medications; MaimoniDex RA Ltd., which is developing a treatment for rheumatoid arthritis; Avraham Pharmaceuticals Ltd., which is developing a treatment for Alzhiemer's Disease; and Lipocure Ltd., which is developing cancer treatments.

Some of these companies have already obtained investments from other sources. The Yissum fund will invest together with other investors in order to maintain its holdings. The fund will not invest in former Yissum companies that have gone public, such as CollPlant Holdings Ltd. (TASE: CLPT) and Biocancell Therapeutics Ltd. (TASE:BICL).

Yissum president and CEO Yaacov Michlin has said in the past that support for graduate portfolio companies as they go through the "valley of death" stage - which he said was between the departure from the laboratory until proof of concept in humans - was the critical component in developing an Israeli biomed industry.

The technology commercialization companies of Israeli universities, particularly Yissum, Yeda R&D Company Ltd., the technology transfer arm of the Weizmann Institute of Science, and Ramot at Tel Aviv University Ltd. are global leaders in technology commercialization.

Published by Globes [online], Israel business news - www.globes-online.com - on June 22, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

Hearst Tower New York credit: Shutterstock Hearst Ventures shuts down Israel office

The closure is part of a global move to shut down offices outside the US, but the fund will continue investment in Israeli companies.

US President Donald Trump credit: Shutterstock US reciprocal procurement demands put Israel in a bind

Reciprocal procurement on major tenders injects billions of dollars into Israel every year and supports hundreds of local companies but Israel may need to relax them in exchange for US tariff cuts.

Israeli stocks on Wall Street credit Nasdaq, Raanan Tal, Itay Tagar, Space Cut design: Tali Bogdanovsky Despite turmoil, analysts bullish on Israel Wall Street stocks

After recent strong declines, analysts are tipping Israeli tech stocks, with relative immunity to recession and limited exposure to tariffs.

Intel's 2025 vision credit: Intel Will Intel's sell-off include Israeli assets?

After the sale of Altera, "Globes" considers whether the troubled chipmaker will sell Mobileye or its Kiryat Gat fab.

CloudShare management team credit: PR Bow River Capital buys Israeli co CloudShare

The Denver-based alternative asset manager is paying an estimated $60-80 million for the SaaS provider of AI guided solutions for complex technical training requirements.

Housing prices continue to rise credit: Tali Bogdanovsky Israel's housing price rise riddle

Despite a huge inventory of unsold new homes in central Israel and weak sales, apartment prices are still rising. "Globes" analyzes the data.

Inflation credit: Tali Bogdanovsky March CPI higher than expected, housing prices rise

The March reading brings annual inflation in Israel down to 3.3% from 3.4% at the end of February.

Ben Gurion airport credit: Tali Bogdanovsky Abundance of affordable last minute Passover flight deals

The return of foreign airlines to Israel has brought down fares dramatically even for last minute vacations.

Karish rig credit: Eyal Izhar Kesem Energy signs gas deals worth $2.8b

The power plant, scheduled to begin operating in 2029, will buy gas worth $2 billion from Energean and a further $700-800 million from the Tamar partners.

Kosher for Passover Coca Cola bottles credit: social media Why are yellow cap Coca Cola bottles different from all others?

Nostalgic Coca Cola aficionados claim that the kosher for Passover version, made from sugar cane instead of high fructose corn syrup, is the genuine taste of the soft drink.

Avigdor Willenz credit: Intel Exclusive: Avigdor Willenz's Element Labs raises $50m

The Israeli startup is developing AI processors for inference, the stage in which AI models are activated after they have already been trained.

Ilya Sutskever credit: Cadya Levy SSI hiring dozens in Israel

AI company Safe Superintelligence is hiring many dozens of people in Tel Aviv, "Globes" has learned.

Johny Srouji credit: Amos Ben Gershom GPO Apple SVP leads senior delegation of execs to Israel

Jony Srouji: I am always filled with renewed energy and optimism about our shared achievements when I visit our R&D centers here.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Ramat Gan, Petah Tikva, Givat Shmuel, Tiberias and Dimona.

Infinity Tower Tel Aviv credit: Courtesy Hagag Group French investors buy 2 Tel Aviv apartments for NIS 27.5m

The two apartments are in Hagag Group's Infinity Tower in the Summeil district.

El Al plane credit: Shutterstock El Al receives state approval to distribute dividend

The Israeli airline has now announced that it will be able to distribute up to 30% of net profit in 2025 and up to 40% in 2026-2028.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018